Peptides have also been studied as potent inhibitors of the p53-MDM2 interaction and a number of these induced p53 mediated cell cycle arrest and apoptosis in solid cancers and hematological malignancies (88, 97–100). This evidence concerns the gene TP53 and hematologic disorder.